ETO – P by Chemisis Pharmaceuticals contains Etodolac, a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation associated with various conditions such as osteoarthritis, rheumatoid arthritis, and acute pain. Etodolac works by inhibiting the enzyme cyclooxygenase (COX), which is involved in the production of prostaglandins, substances that mediate inflammation and pain in the body. The typical dosage of ETO – P is one 400 mg tablet taken orally, usually once or twice daily, depending on the severity of the condition and the patient’s response to the medication. It is important to take Etodolac with food or milk to minimize the risk of gastrointestinal side effects. Common side effects of Etodolac may include nausea, vomiting, stomach pain, indigestion, diarrhea, constipation, dizziness, and headache. Serious side effects are rare but can include gastrointestinal bleeding, ulcers, heart attack, stroke, high blood pressure, kidney problems, and severe allergic reactions. Patients should seek immediate medical attention if they experience symptoms such as chest pain, shortness of breath, weakness on one side of the body, slurred speech, or swelling of the face or throat.